【摘 要】
：
In addition to symptomatic relief of symptoms and an increase in angina-free walking time with antianginal drugs or revascularization procedures,the recent emphasis of treatment has been to reduce adv
【出 处】
：
中国老年学会体外反搏与心血管康复论坛暨第二届国际体外反搏学术交流会
论文部分内容阅读
In addition to symptomatic relief of symptoms and an increase in angina-free walking time with antianginal drugs or revascularization procedures,the recent emphasis of treatment has been to reduce adverse clinical outcomes (coronary death and myocardial infarction).The role of smoking cessation,aspirin,treatment of elevated lipids,and treatment of high blood pressure in all patients and of beta-blockers and angiotensin-converting enzyme inhibitors in patients with diminished systolic left ventricular systolic function in reducing adverse outcomes has been well established.What is unknown,however,is whether any anti-anginal drugs (beta-blockers,long-acting nitrates,calcium channel blockers) affect adverse outcomes in patients with stable angina pectoris.
其他文献
We report our experience using the new noninvasive treatment for coronary patients called enhanced external counterpulsation (EECP).Thallium-201 stress scintigraphy and treadmill test were done before
Enhanced extemal counterpulsation (EECP) is a noninvasive procedure,in which compressions are applied to the vascular beds within the muscles of the legs,thighs,and buttocks in a sequential manner,pro
Enhanced external counterpulsation (EECP) is a noninvasive treatment for chronic stable angina,which works by recruiting and developing the coronary collateral vessels.Coronary perfusion and coronary
Enhanced external counter pulsation is a noninvasive therapy that uses sequentially inflated pneumatic cuffs on the lower extremities to enhance coronary artery diastolic flow and decrease left ventri